A Study of the Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.

Glaukos Corporation58 enrolled

Overview

To evaluate the safety and efficacy of a new trabecular bypass that is implanted in conjunction with cataract surgery in open angle glaucoma subjects.

Glaukos Corporation conducted a clinical research study at multiple investigational sites within Europe (8)

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Open-Angle Glaucoma

Interventions

iStentDEVICE

Glaucoma Surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with primary open-angle glaucoma (POAG) * Subject on at least one glaucoma medication * Patient requiring cataract surgery and an intraocular lens implantation Exclusion Criteria: * Prior glaucoma procedures (eg trabeculectomy, viscocanalostomy, ALT, SLT, shunt implant, collagen implant, cyclo destructive procedures etc) * Angle closure glaucoma

Locations (8)

Klinik Vincentinum

Augsburg, Germany

Universitats Augenklinik

Freiburg im Breisgau, Germany

Rotkreuz Krankenhaus

München, Germany

Klinikum Neubrandenburg

Neubrandenburg, Germany

Outcomes

Primary Outcomes

Efficacy

Time frame: 24 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.